Notice2022-15741
National Center for Health Statistics (NCHS), ICD-10 Coordination and Maintenance (C&M) Committee Meeting.
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 22, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The CDC, National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting of the ICD-10 Coordination and Maintenance (C&M) Committee. This meeting is open to the public, limited only by the number of audio lines available. Online registration is not required.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 140 (Friday, July 22, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 140 (Friday, July 22, 2022)]
[Notices]
[Pages 43861-43862]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-15741]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Center for Health Statistics (NCHS), ICD-10 Coordination
and Maintenance (C&M) Committee Meeting.
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The CDC, National Center for Health Statistics (NCHS),
Classifications and Public Health Data Standards Staff, announces the
following meeting of the ICD-10 Coordination and Maintenance (C&M)
Committee. This meeting is open to the public, limited only by the
number of audio lines available. Online registration is not required.
DATES: The meeting will be held on September 13, 2022, from 9 a.m. to 5
p.m., EDT, and September 14, 2022, from 9 a.m. to 5 p.m., EDT.
ADDRESSES: This is a virtual meeting. Information will be provided on
each of the respective web pages when it becomes available. For CDC,
NCHS: <a href="https://www.cdc.gov/nchs/icd/icd10cm_maintenance.htm">https://www.cdc.gov/nchs/icd/icd10cm_maintenance.htm</a>. For the
Centers for Medicare & Medicaid Services (CMS), HHS: <a href="https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials">https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials</a>.
FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Medical Systems
Specialist, CDC, NCHS, 3311 Toledo Road, Hyattsville, Maryland 20782-
2064; Telephone: (301) 458-4454; Email: <a href="/cdn-cgi/l/email-protection#5b0f093a3632293e211b383f38753c342d"><span class="__cf_email__" data-cfemail="560204373b3f24332c1635323578313920">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The ICD-10 Coordination and Maintenance Committee is a
public forum for the presentation of proposed modifications to the
International Classification of Diseases, Tenth Revision, Clinical
Modification (CM) and ICD-10 Procedure Coding System (PCS).
Matters To Be Considered: The tentative agenda will include
discussions on the ICD-10-CM and ICD-10-PCS topics listed below. Agenda
items are subject to change as priorities dictate. Please refer to the
posted agenda for updates one month prior to the meeting.
[[Page 43862]]
ICD-10-PCS Topics
1. Administration of Lovotibeglogene autotemcel (lovo-cel) *
2. Administration of Exagamglogene autotemcel (exa-cel) **
3. External Support Device for AV Fistula Creation
4. Implantation of Polymethyl Methacrylate Cranioplasty Plates *
5. Insertion of Transcatheter Bicaval Valve System *
6. Implantation of Bioprosthetic Femoral Venous Valve
7. Intubated Prone Positioning
8. Section X Updates
9. Addenda and Key Updates
* Requestor intends to submit a new technology add-on payment
(NTAP) application for FY 2024.
** Request is for an April 1, 2023, implementation date, and the
requestor intends to submit an NTAP application for FY 2024
consideration.
Presentations for procedure code requests are conducted by both the
requestor and CMS during the C&M Committee meeting. Discussion from the
requestor generally focuses on the clinical issues for the procedure or
technology, followed by the proposed coding options from a CMS analyst.
Topics presented may also include requests for new procedure codes that
relate to a new technology add-on payment (NTAP) policy request.
CMS is continuing to modify the approach for presenting the new
NTAP-related ICD-10-PCS procedure code requests that involve the
administration of a therapeutic agent for the September 13-14, 2022,
ICD-10 Coordination and Maintenance Committee meeting. Consistent with
the requirements of section 1886(d)(5)(K)(iii) of the Social Security
Act, applicants submitted requests to create a unique procedure code to
describe the administration of a therapeutic agent, such as the option
to create a new code in Section X within the ICD-10-PCS procedure code
classification. CMS will initially display only those meeting materials
associated with the NTAP-related ICD-10-PCS procedure code requests
that involve the administration of a therapeutic agent on the CMS
website in early August 2022 at: <a href="https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials">https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials</a>.
The two NTAP-related ICD-10-PCS procedure code requests that
involve the administration of a therapeutic agent are:
1. Administration of Lovotibeglogene autotemcel (lovo-cel) *
2. Administration of Exagamglogene autotemcel (exa-cel) **
These topics will not be presented during the September 13-14,
2022, meeting. CMS will solicit public comments regarding any clinical
questions or coding options included for these two procedure code
topics in advance of the meeting continuing through the end of the
respective public comment periods. Members of the public should send
any questions or comments to the CMS mailbox at:
<a href="/cdn-cgi/l/email-protection#97ded4d3c7e5f8f4f2f3e2e5f2d4f8f3f2c5f2e6e2f2e4e3d7f4fae4b9ffffe4b9f0f8e1"><span class="__cf_email__" data-cfemail="672e2423371508040203121502240803023502161202141327040a14490f0f1449000811">[email protected]</span></a>.
CMS intends to post a question-and-answer document in advance of
the meeting to address any clinical or coding questions that members of
the public may have submitted. Following the conclusion of the meeting,
CMS will post an updated question-and-answer document to address any
additional clinical or coding questions that members of the public may
have submitted during the meeting that CMS was not able to address or
that were submitted after the meeting.
The NTAP-related ICD-10-PCS procedure code requests that do not
involve the administration of a therapeutic agent and all non-NTAP-
related procedure code requests will continue to be presented during
the virtual meeting on September 13, 2022, consistent with the standard
meeting process.
CMS will make all meeting materials and related documents available
at: <a href="https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials">https://www.cms.gov/Medicare/Coding/ICD10/C-and-M-Meeting-Materials</a>. Any inquiries related to the procedure code topics scheduled
for the September 13-14, 2022, ICD-10 Coordination and Maintenance
Committee meeting that are under consideration for April 1, 2023, or
October 1, 2023, implementation should be sent to the CMS mailbox at:
<a href="/cdn-cgi/l/email-protection#1e575d5a4e6c717d7b7a6b6c7b5d717a7b4c7b6f6b7b6d6a5e7d736d3076766d30797168"><span class="__cf_email__" data-cfemail="0148424551736e626465747364426e65645364707464727541626c722f6969722f666e77">[email protected]</span></a>.
ICD-10-CM Topics
1. Extraocular Muscle Entrapment
2. IGAN
3. Inappropriate Sinus Tachycardia
4. Insulin Resistance Syndrome
5. Leukodystrophies
6. Nontraumatic Coma Not Elsewhere Classified
7. Sickle Cell Retinopathy
8. Addenda
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-15741 Filed 7-21-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 22, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.